Acquisition (code M) of 14,475 shares at $0 per share.
Reporting Person WEAVER GREGORY L · Officer Title Chief Financial Officer · Transaction Code M
Traded Oct 1, 2026 · Disclosed Oct 5, 2026
Source: SEC Form 4 · 0001251779-26-000011 · filed 2026-10-05 · View filing →
Disposition (code F) of 4,379 shares at $2.76 per share.
Reporting Person WEAVER GREGORY L · Officer Title Chief Financial Officer · Transaction Code F
Traded Oct 1, 2026 · Disclosed Oct 5, 2026
Source: SEC Form 4 · 0001251779-26-000011 · filed 2026-10-05 · View filing →
Acquisition (code M) of 37,500 shares at $0 per share.
Reporting Person Arbet-Engels Christophe · Officer Title Chief Medical Officer · Transaction Code M
Traded Oct 1, 2026 · Disclosed Oct 5, 2026
Source: SEC Form 4 · 0001802615-26-000002 · filed 2026-10-05 · View filing →
Disposition (code F) of 12,679 shares at $2.76 per share.
Reporting Person Arbet-Engels Christophe · Officer Title Chief Medical Officer · Transaction Code F
Traded Oct 1, 2026 · Disclosed Oct 5, 2026
Source: SEC Form 4 · 0001802615-26-000002 · filed 2026-10-05 · View filing →
Acquisition (code M) of 24,000 shares at $0 per share.
Reporting Person Richardson Linda M · Officer Title Chief Commercial Officer · Transaction Code M
Traded Sep 16, 2026 · Disclosed Sep 17, 2026
Source: SEC Form 4 · 0001595064-26-000002 · filed 2026-09-17 · View filing →
Disposition (code F) of 6,826 shares at $3.24 per share.
Reporting Person Richardson Linda M · Officer Title Chief Commercial Officer · Transaction Code F
Traded Sep 16, 2026 · Disclosed Sep 17, 2026
Source: SEC Form 4 · 0001595064-26-000002 · filed 2026-09-17 · View filing →
Purchase of 15,000 shares at $2.95 per share.
Reporting Person Durso Jerome Benedict · Officer Title President and CEO · Transaction Code P
Traded Aug 13, 2026 · Disclosed Aug 13, 2026
Source: SEC Form 4 · 0001698665-26-000007 · filed 2026-08-13 · View filing →